Keywords
symptoms
Post COVID-19 Syndrome
epidemiology
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objetivo: Verificar características clínicas y epidemiológicas de los pacientes afectados por COVID-19 y analizar los principales síntomas post-COVID-19 y sus repercusiones clínicas. Métodos: Se trata de un estudio transversal observacional, con 311 participantes de ambos sexos, mayores de 18 años y con diagnóstico de COVID-19 confirmado por pruebas. La recolección de datos se realizó entre julio/2021 y febrero/2022, mediante el llenado de un formulario creado en Google Forms, que fue difundido a través de las redes sociales. El estudio fue aprobado por el Comité de Ética en Investigación. Resultados: El 69,13% de los participantes son mujeres, con una edad media de 32,0 ± 12,61. Hubo una baja tasa de hospitalización en UCI y una baja tasa de recurrencia de COVID-19. Fatiga, pérdida/disminución del sentido del olfato y paladar, dificultad persistente para respirar y cansancio al mínimo esfuerzo fueron características predominantes durante más de 3 semanas en los participantes. Los síntomas menos prevalentes incluyeron cambios en la función excretora, falta de aire persistente, pérdida/disminución del apetito, de cabello, tos y dolor de cabeza. Conclusión: Los hallazgos corroboran la comprensión del Síndrome Post-COVID-19 y son congruentes con la literatura, denotando la condición multisistémica que la enfermedad trae, especialmente a largo plazo.
References
ABDEL-GAWAD M, et al. Post-COVID-19 Syndrome Clinical Manifestations: A Systematic Review. Antiinflamm Antiallergy Agents Med Chem., 2022; 21(2): 115-20.
ANAYA JM, et al. Post-COVID syndrome: A case series and comprehensive review. Autoimmun Rev., 2021; 20 (11): 102947.
BAIG AM. Chronic COVID Syndrome: Need for appropriate medical terminology for Long-COVID and COVID Long-Haulers. J Med Virol., 2020.
BATIBAY S, et al. The prevalence and clinical spectrum of post-Covid syndrome in patients with rheumatic diseases: a single-center experience. Reumatismo, 2022; 3; 74(1).
CAROD-ARTAL FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol., 2021; 72: 384-96.
CEBAN F, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun., 2022; 101: 93-135.
CHHABRA N, et al. Post-COVID Headache: A Literature Review. Curr Pain Headache Rep., 2022; 26(11): 835-842.
CZECH T, et al. Characteristics of hair loss after COVID-19: A systematic scoping review. J Cosmet Dermatol., 2022; 21(9): 3655-3662.
DAVIES HE, et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. Disponível em: https://www.medrxiv.org/content/10.1101/2020.12.24.20248802v2. Acesso em: 29 Jan 2021.
DELGADO-ALONSO C, et al. Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID Syndrome. Int J Environ Res Public Health, 2022; 16; 19(20): 13368.
FETER N, et al. Physical activity and long COVID: findings from the Prospective Study About Mental and Physical Health in Adults cohort. Public Health, 2023; 220: 148-154.
GREENHALGH T, et al. Management of post-acute covid-19 in primary care. BMJ 2020; 370.
LADDS E, et al. Persistent symptoms after Covid-19: a qualitative study of 114 “long Covid” patients and draft quality principles for services. BMC Health Serv Res., 2020; 20 (1144).
LI B, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol., 2020; 109(5): 531-8.
MAGLIETTA G, et al. Prognostic Factors for Post-COVID-19 Syndrome: a Systematic Review and Meta-Analysis. J Clin Med., 2022; 11(6).
MALIK P, et al. Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL): A systematic review and meta‐analysis. J Med Virol., 2022; 94(1): 253-262.
MARJENBERG Z, et al. Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis. Sci Rep., 2023; 13(1): 15332.
MENDELSON M, et al. Long-COVID: An evolving problem with an extensive impact. S Afr Med J., 2020; 111(1): 10-2.
NOTARTE KI, et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J Clin Med., 2022; 11(24): 7314.
RAVEENDRAN AV, et al. Post COVID-19 Syndrome ("Long COVID") and Diabetes: Challenges in Diagnosis and Management. Diabetes Metab Syndr., 2021; 15(5): 102235.
SALAMANNA F, et al. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med., 2021; 8.
WANG B, et al. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging, 2020; 12(7): 6049-57.
WOODWARD SF, et al. Anxiety, Post–COVID-19 Syndrome-Related Depression, and Suicidal Thoughts and Behaviors in COVID-19 Survivors: Cross-sectional Study. JMIR Form Res., 2022; 25;6(10): e36656.
YANG J, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis., 2020; 94: 91-5.